1mg acquires Medd.in
The e-diagnostic service of 1mg is currently available across 23 cities
India’s premier digital health destination 1mg has announced that it has acquired Medd.in, a platform that operates a marketplace for booking diagnostic & imaging tests. Medd.in was co-founded by IIT Bombay graduates Arpit Kothari and Anurag Mundhada and Carnegie Mellon graduate Era Dwivedi in 2015. They have now joined the 1mg team. Medd operates across Mumbai, Indore, Bhopal, Nagpur, Bangalore and Jaipur.
“With this acquisition, we are accelerating our drive to provide best healthcare to our customers,” said Prashant Tandon, CEO 1mg. “Together with Medd, we see a unique opportunity to amplify our leadership position and enter new geographies as well as the Radiology segment.”
“We are looking forward to working as a part of the team at 1mg and leveraging the scale of the platform to build on our vision to simplify and make high quality diagnostic services affordable to all,” said Arpit, co-founder and CEO Medd. “Medd is a splendid solution to a serious pain point. I congratulate the folks at 1mg for picking up this great asset. Both are stronger as a result of this acquisition,” said Ajeet Khurana, investor in Medd
The e-diagnostic service of 1mg is currently available across 23 cities, powered by tie ups with top-quality certified laboratories. Users book an appointment for at-home sample collection and receive their test results online with the added option of receiving a paper copy. By using the 1mg platform, users can make savings of 40-60% on their lab tests requirements.